Full text
PDF![1](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7997/1356998/88754ef702c2/jphysiol01300-0023.png)
![2](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7997/1356998/effbff7f61c4/jphysiol01300-0024.png)
![3](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7997/1356998/c65e1dab25da/jphysiol01300-0025.png)
![4](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7997/1356998/9ec45f8812cb/jphysiol01300-0026.png)
![5](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7997/1356998/0747d2cd1ae6/jphysiol01300-0027.png)
![6](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7997/1356998/6da91852dfca/jphysiol01300-0028.png)
![7](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7997/1356998/4863544ab91e/jphysiol01300-0029.png)
![8](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7997/1356998/e1ca68fbab09/jphysiol01300-0030.png)
![9](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7997/1356998/0e0b1e6ac574/jphysiol01300-0031.png)
![10](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7997/1356998/9577510fcd12/jphysiol01300-0032.png)
![11](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7997/1356998/fd2352be6b52/jphysiol01300-0033.png)
![12](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7997/1356998/c3f7fb71941e/jphysiol01300-0034.png)
![13](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7997/1356998/37bbb04b5aa1/jphysiol01300-0035.png)
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- AMBACHE N. The use and limitations of atropine for pharmacological studies on autonomic effectors. Pharmacol Rev. 1955 Dec;7(4):467–494. [PubMed] [Google Scholar]
- BROOKS V. B. An intracellular study of the action of repetitive nerve volleys and of botulinum toxin on miniature end-plate potentials. J Physiol. 1956 Nov 28;134(2):264–277. doi: 10.1113/jphysiol.1956.sp005642. [DOI] [PMC free article] [PubMed] [Google Scholar]
- BROOKS V. B. The action of botulinum toxin on motor-nerve filaments. J Physiol. 1954 Mar 29;123(3):501–515. doi: 10.1113/jphysiol.1954.sp005067. [DOI] [PMC free article] [PubMed] [Google Scholar]
- BURN J. H., RAND M. J. Noradrenaline in artery walls and its dispersal by reserpine. Br Med J. 1958 Apr 19;1(5076):903–908. doi: 10.1136/bmj.1.5076.903. [DOI] [PMC free article] [PubMed] [Google Scholar]
- FOLKOW B. Nervous control of the blood vessels. Physiol Rev. 1955 Jul;35(3):629–663. doi: 10.1152/physrev.1955.35.3.629. [DOI] [PubMed] [Google Scholar]
- HILTON S. M., LEWIS G. P. The cause of the vasodilatation accompanying activity in the submandibular salivary gland. J Physiol. 1955 May 27;128(2):235–248. doi: 10.1113/jphysiol.1955.sp005302. [DOI] [PMC free article] [PubMed] [Google Scholar]
- HILTON S. M. The effects of nicotine on the blood vessels of skeletal muscle in the cat; an investigation of vasomotor axon reflexes. J Physiol. 1954 Feb 26;123(2):289–300. doi: 10.1113/jphysiol.1954.sp005051. [DOI] [PMC free article] [PubMed] [Google Scholar]
- HOLTON P. Antidromic vasodilatation and inhibitors of cholinesterase. J Physiol. 1953 Apr 28;120(1-2):95–104. doi: 10.1113/jphysiol.1953.sp004875. [DOI] [PMC free article] [PubMed] [Google Scholar]
- HOLTON P., PERRY W. L. M. On the transmitter responsible for antidromic vasodilatation in the rabbit's ear. J Physiol. 1951 Jun;114(1-2):240–251. doi: 10.1113/jphysiol.1951.sp004615. [DOI] [PMC free article] [PubMed] [Google Scholar]
- KOTTEGODA S. R. The action of nicotine and acetylcholine on the vessels of the rabbit's ear. Br J Pharmacol Chemother. 1953 Jun;8(2):156–161. doi: 10.1111/j.1476-5381.1953.tb00770.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- LANIER J. T., GREEN H. D., HARDAWAY J., JOHNSON H. D., DONALD W. B. Fundamental difference in the reactivity of the blood vessels in skin compared with those in muscle; blood flow response in these two beds to ischemia, and to intra-arterial injections of methacholine, epinephrine and noradrenalin before and after administration of antiadrenergic drugs. Circ Res. 1953 Jan;1(1):40–48. doi: 10.1161/01.res.1.1.40. [DOI] [PubMed] [Google Scholar]
- PAGE I. H., McCUBBIN J. W. Cardiovascular action of 1,1-dimethyl-4-phenylpiperazinium iodide (DMPP); a ganglion stimulating agent useful in the diagnosis of pheochromocytoma. Am J Med. 1953 Nov;15(5):675–683. doi: 10.1016/0002-9343(53)90156-9. [DOI] [PubMed] [Google Scholar]
- SHIPLEY R. E., WILSON C. An improved recording rotameter. Proc Soc Exp Biol Med. 1951 Dec;78(3):724–728. doi: 10.3181/00379727-78-19196. [DOI] [PubMed] [Google Scholar]
- UVNAS B. Sympathetic vasodilator outflow. Physiol Rev. 1954 Jul;34(3):608–618. doi: 10.1152/physrev.1954.34.3.608. [DOI] [PubMed] [Google Scholar]
- WINBURY M. M. Comparison of the vascular actions of 1,1-dimethyl-4-phenyl-piperazinium and tetramethylammonium. J Pharmacol Exp Ther. 1958 Sep;124(1):25–34. [PubMed] [Google Scholar]
- WINBURY M. M., MICHIELS P. M., HAMBOURGER W. E., STOCKFISCH W. J., COOK D. L. Coronary dilator action. I. Quantitative assay in the intact dog. J Pharmacol Exp Ther. 1950 Jul;99(3):343–349. [PubMed] [Google Scholar]
- WINBURY M. M. Muscarinic action of murexine and some related choline esters. Nature. 1957 Nov 9;180(4593):988–989. doi: 10.1038/180988a0. [DOI] [PubMed] [Google Scholar]
- WINBURY M. M., WOLF J. K., TABACHNICK I. I. Cardiovascular actions of three choline esters of carboxyalkylimidazole. J Pharmacol Exp Ther. 1958 Feb;122(2):207–214. [PubMed] [Google Scholar]
- WRIGHT G. P. The neurotoxins of Clostridium botulinum and Clostridium tetani. Pharmacol Rev. 1955 Dec;7(4):413–465. [PubMed] [Google Scholar]
- YOUMANS P. L., GREEN H. D., DENISON A. B., Jr Nature of the vasodilator and vasoconstrictor receptors in skeletal muscle of the dog. Circ Res. 1955 Mar;3(2):171–180. doi: 10.1161/01.res.3.2.171. [DOI] [PubMed] [Google Scholar]